Literature DB >> 8466482

Cloning of a variant epidermal growth factor receptor.

T Moriai1, M S Kobrin, M Korc.   

Abstract

The sequences encoding the full-length epidermal growth factor receptor (EGFR) were cloned from a cDNA library prepared from T3M4 cells. A transition (G to A) was identified at codon 497 of EGFR cDNA, resulting in the substitution of a lysine for an arginine. The same substitution was identified by sequencing cDNA derived from 3 of 7 additional human pancreatic cancer cell lines, one endometrial cancer cell line, and one lung cancer cell line, but not in A431 cells. Variant EGFR was always co-expressed with wild-type EGFR. Both sequences were present in genomic DNA from two cell lines expressing the variant receptor and in DNA from normal (3 of 7 individuals) human lymphocytes. These findings indicate that there are two alleles in this region of the EGFR gene, and that expression of variant EGFR is a common occurrence in normal and cancerous cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466482     DOI: 10.1006/bbrc.1993.1321

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Establishment and characterization of a new hamster pancreatic cancer cell line: the biological activity and the binding characteristics of EGF or TGF-alpha.

Authors:  Y Morita; T Moriai; Y Takiyama; I Makino
Journal:  Int J Pancreatol       Date:  1998-02

2.  A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.

Authors:  T Moriai; M S Kobrin; C Hope; L Speck; M Korc
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

3.  Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.

Authors:  Charles M Rudin; Wanqing Liu; Apurva Desai; Theodore Karrison; Xuemin Jiang; Linda Janisch; Soma Das; Jacqueline Ramirez; Balasubramanian Poonkuzhali; Erin Schuetz; Donna Lee Fackenthal; Peixian Chen; Deborah K Armstrong; Julie R Brahmer; Gini F Fleming; Everett E Vokes; Michael A Carducci; Mark J Ratain
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

4.  A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.

Authors:  Yinsheng Wang; Lidan Zha; Dan Liao; Xiaozhi Li
Journal:  Int J Genomics       Date:  2014-10-21       Impact factor: 2.326

5.  Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma.

Authors:  Haisheng Guo; Yunhui Xing; Ailan Mu; Xia Li; Tingshan Li; Xia Bian; Chunmei Yang; Xiaolei Zhang; Yuefen Liu; Xunguo Wang
Journal:  Onco Targets Ther       Date:  2016-08-25       Impact factor: 4.147

6.  A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment.

Authors:  Anthony Gonçalves; Séverine Esteyries; Brynn Taylor-Smedra; Arnaud Lagarde; Mounay Ayadi; Geneviève Monges; François Bertucci; Benjamin Esterni; Jean-Robert Delpero; Olivier Turrini; Bernard Lelong; Patrice Viens; Jean-Paul Borg; Daniel Birnbaum; Sylviane Olschwang; Frédéric Viret
Journal:  BMC Cancer       Date:  2008-06-10       Impact factor: 4.430

7.  R497K polymorphism in epidermal growth factor receptor gene is associated with the risk of acute coronary syndrome.

Authors:  Lin-Bo Gao; Bin Zhou; Lin Zhang; Ye-Sheng Wei; Yan-Yun Wang; Wei-Bo Liang; Mei-Li Lv; Xin-Min Pan; Yu-Cheng Chen; Li Rao
Journal:  BMC Med Genet       Date:  2008-07-30       Impact factor: 2.103

8.  Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study.

Authors:  Chong Li; Rongrong Wei; Yava L Jones-Hall; Ragini Vittal; Min Zhang; Wanqing Liu
Journal:  Sci Rep       Date:  2014-05-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.